Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $4.1 million.

  • Biodesix's Cost of Revenue fell 174.68% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 1079.77%. This contributed to the annual value of $15.6 million for FY2024, which is 1970.02% up from last year.
  • Per Biodesix's latest filing, its Cost of Revenue stood at $4.1 million for Q3 2025, which was down 174.68% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Cost of Revenue ranged from a high of $18.2 million in Q1 2021 and a low of $2.5 million during Q4 2021
  • For the 5-year period, Biodesix's Cost of Revenue averaged around $4.5 million, with its median value being $3.6 million (2022).
  • Examining YoY changes over the last 5 years, Biodesix's Cost of Revenue showed a top increase of 105230.87% in 2021 and a maximum decrease of 8298.53% in 2021.
  • Biodesix's Cost of Revenue (Quarter) stood at $2.5 million in 2021, then surged by 32.61% to $3.3 million in 2022, then grew by 2.06% to $3.4 million in 2023, then grew by 28.69% to $4.3 million in 2024, then decreased by 5.44% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $4.0 million for Q2 2025, and $3.7 million during Q1 2025.